NIVF vs BDRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

NIVF

32.4
AI Score
VS
NIVF Wins

BDRX

25.8
AI Score

Investment Advisor Scores

NIVF

32score
Recommendation
AVOID NEW MONEY

BDRX

26score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric NIVF BDRX Winner
Forward P/E 0.0015 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -4.7% -64.1% NIVF
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 32.4/100 25.8/100 NIVF
Profit Margin 24.2% 0.0% NIVF
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

NIVF 1M: +19.9% · 3M: -46.0% BDRX 1M: +542.0% · 3M: +64.0%

Current Technical Phase

NIVF

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 40.1 · Price: $0.28

BDRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (29.5% over 20 days), RSI 58

RSI (14): 58.2 · Price: $2.46

Fundamentals Snapshot

Metric NIVF BDRX
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E — 0.0
Revenue (TTM) — —
Revenue Growth 0.0% -0.6%
Gross Margin 0.2% -62.8%
Operating Margin -1.8% 0.0%
EPS -34064.71 512.05
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NIVF is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.